logo
welcome
Guardian

Guardian

Which disease-modifying Alzheimer’s drugs are the most promising?

Guardian
Summary
Nutrition label

80% Informative

Donanemab and lecanemab were approved by the UK ’s Medicines and Healthcare products Regulatory Agency.

Yet the National Institute for Health and Care Excellence (Nice ) said their benefits were too small to justify their costs.

There have also been concerns over potential side-effects such as brain swelling and bleeding.

VR Score

74

Informative language

68

Neutral language

71

Article tone

semi-formal

Language

English

Language complexity

55

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

Affiliate links

no affiliate links